Request to Cover – 2:00 P.M. ET, September 25: Join the UN Science Summit Session Exploring New Thinking On Applying Microbiome Science To Address Childhoood Malnutrition
Media, Press Release
Share
Contacts:
dhfusilli@gmail.com +1(914)649-0803
media@openbiome.org 1(617)840-211
What: “Why the Gut Microbiome is Critical to Children’s Health: Harnessing Microbiome Science to End Malnutrition” is a seminal discussion at the UN Science Summit as ramp up to the UN Summit of the Future.
Why: Despite advances in child health, few therapeutic advances in malnutrition have occurred over the past 30 years. New research on the gut microbiome offers the promise of transformative therapeutics.
Who: Open Biome, a pioneering nonprofit microbiome health organization, is hosting global leaders:
Julie Barrett O’Brien
Chief Executive Officer, OpenBiome
Dr. Majdi Osman
Chief Medical Officer, OpenBiome
Dr. Jeffrey I. Gordon
Dr. Robert J. Glaser Distinguished University Professor and Director of the Center for Genome Sciences and Systems Biology at Washington University in St. Louis
Dr. Billo Tall
Manager, Clinical Research, Institut Pasteur de Dakar, Senegal
Dr. Tahmeed Ahmed
Executive Director, icddr,b, Bangladesh
Dr. Vanessa Ridaura
Senior Program Officer, Microbiome Products, The Bill & Melinda Gates Foundation
Dr. Nigel Rollins
Scientist, WHO Department of Maternal, Newborn, Child and Adolescent Health and Aging
Hilina Belete
General Manager, Hilina Enriched Foods, Ethiopia
When: 2:00 – 4:00 p.m, September 25, 2024
Where: In person, Cure, 345 Park Ave South, NYC and online.
Panelists and UN Science Summit hosts are available for interviews and backgrounders. What are they saying?
Declan Killane, Managing Director, ISC Intelligence, Chairman and Managing Director, UN Science Summit: “OpenBiome is critically important to the global nutrition agenda. We need to ensure that their endeavors are reflected in the UN and member states policies and related research funding. The UN Summit of the Future is the perfect opportunity to advance this agenda for the benefit of all.”
Dr. Billo Tall: “Fighting malnutrition is essential to building healthy, sustainable communities. Every step we take in this direction is a step towards a future where every child has the chance to reach their full potential.”
Dr. Jeffrey Gordon: “Developing and implementing microbiome-directed therapeutics for maternal and childhood undernutrition requires a great level of interdisciplinary thinking, inter-institutional cooperation and collaboration, and sustained long-term support. Early demonstration projects in a few select LMICs can provide examples of how such programs could/should be designed and executed.
These programs represent a means to study the mechanisms underlying, and to effectively treat, a variety of microbiome-associated diseases in various areas of the world, including Southeast Asia, Sub-Saharan Africa and Latin America.”
Dr. Vanessa Ridaura: “Tremendous progress in addressing child health has been made over the last two decades, and focusing on nutrition can help us achieve more. Understanding the microbiome will be key to unlocking the next generation of solutions to fight child malnutrition — from tools to rebuild a child’s microbiome, to helping women improve their gut health before pregnancy. Working together, philanthropies, governments and researchers can accelerate the discovery of these tools and then put ting them into action faster for children around the world.”
Julie Barrett O’Brien: “We are on the cusp of a paradigm shift in how we treat malnutrition but translating scientific research into action requires a broad range of disciplines. We need to move quickly from scientific proof to action. Our early work supports the need for new policies, funders and partners around microbiome therapeutics for malnutrition. Let’s make it so.”
# # #
OpenBiome accelerates microbiome science and therapeutics to improve health for all. The nonprofit partners with leading researchers, clinicians and innovators to advance and ensure access to novel and affordable microbiome therapeutics. For more information: openbiome.org